
### [NCIT:C8504](http://purl.obolibrary.org/obo/NCIT_C8504)
**Label:** Indolent Non-Hodgkin Lymphoma

**Subclasses:** [NCIT:C4997](http://purl.obolibrary.org/obo/NCIT_C4997) (Refractory Nodal Marginal Zone Lymphoma), [NCIT:C5768](http://purl.obolibrary.org/obo/NCIT_C5768) (Liver Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C4998](http://purl.obolibrary.org/obo/NCIT_C4998) (Recurrent Nodal Marginal Zone Lymphoma), [NCIT:C3465](http://purl.obolibrary.org/obo/NCIT_C3465) (Grade 1 Follicular Lymphoma), [NCIT:C45163](http://purl.obolibrary.org/obo/NCIT_C45163) (Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45166](http://purl.obolibrary.org/obo/NCIT_C45166) (Campylobacter Jejuni-Associated Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8117](http://purl.obolibrary.org/obo/NCIT_C8117) (Stage II Grade 2 Follicular Lymphoma), [NCIT:C7305](http://purl.obolibrary.org/obo/NCIT_C7305) (Splenic Lymphoplasmacytic Lymphoma), [NCIT:C5088](http://purl.obolibrary.org/obo/NCIT_C5088) (Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8116](http://purl.obolibrary.org/obo/NCIT_C8116) (Stage II Grade 1 Follicular Lymphoma), [NCIT:C5089](http://purl.obolibrary.org/obo/NCIT_C5089) (Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155) (Recurrent Grade 1 Follicular Lymphoma), [NCIT:C8156](http://purl.obolibrary.org/obo/NCIT_C8156) (Recurrent Grade 2 Follicular Lymphoma), [NCIT:C5085](http://purl.obolibrary.org/obo/NCIT_C5085) (Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5086](http://purl.obolibrary.org/obo/NCIT_C5086) (Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7264](http://purl.obolibrary.org/obo/NCIT_C7264) (Diffuse Follicular Lymphoma), [NCIT:C5087](http://purl.obolibrary.org/obo/NCIT_C5087) (Stage III Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), [NCIT:C8482](http://purl.obolibrary.org/obo/NCIT_C8482) (Stage III Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C95626](http://purl.obolibrary.org/obo/NCIT_C95626) (Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C68678](http://purl.obolibrary.org/obo/NCIT_C68678) (Stage I Marginal Zone Lymphoma), [NCIT:C7194](http://purl.obolibrary.org/obo/NCIT_C7194) (Grade 2 Diffuse Follicular Lymphoma), [NCIT:C68679](http://purl.obolibrary.org/obo/NCIT_C68679) (Stage II Marginal Zone Lymphoma), [NCIT:C35794](http://purl.obolibrary.org/obo/NCIT_C35794) (Pagetoid Reticulosis), [NCIT:C5090](http://purl.obolibrary.org/obo/NCIT_C5090) (Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C8968](http://purl.obolibrary.org/obo/NCIT_C8968) (Grade 2 Follicular Lymphoma), [NCIT:C27763](http://purl.obolibrary.org/obo/NCIT_C27763) (Helicobacter Pylori-Associated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C7798](http://purl.obolibrary.org/obo/NCIT_C7798) (Stage II Mycosis Fungoides), [NCIT:C8604](http://purl.obolibrary.org/obo/NCIT_C8604) (Recurrent Lymphoplasmacytic Lymphoma), [NCIT:C8129](http://purl.obolibrary.org/obo/NCIT_C8129) (Stage III Grade 1 Follicular Lymphoma), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C8687](http://purl.obolibrary.org/obo/NCIT_C8687) (Refractory Mycosis Fungoides), [NCIT:C44960](http://purl.obolibrary.org/obo/NCIT_C44960) (Chlamydia Psittaci-Associated Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C7796](http://purl.obolibrary.org/obo/NCIT_C7796) (Stage I Mycosis Fungoides), [NCIT:C8686](http://purl.obolibrary.org/obo/NCIT_C8686) (Recurrent Mycosis Fungoides), [NCIT:C8488](http://purl.obolibrary.org/obo/NCIT_C8488) (Recurrent Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C95991](http://purl.obolibrary.org/obo/NCIT_C95991) (Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5498](http://purl.obolibrary.org/obo/NCIT_C5498) (Colon Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C7230](http://purl.obolibrary.org/obo/NCIT_C7230) (Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5095](http://purl.obolibrary.org/obo/NCIT_C5095) (Recurrent Splenic Marginal Zone Lymphoma), [NCIT:C8485](http://purl.obolibrary.org/obo/NCIT_C8485) (Stage IV Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C5096](http://purl.obolibrary.org/obo/NCIT_C5096) (Refractory Splenic Marginal Zone Lymphoma), [NCIT:C8130](http://purl.obolibrary.org/obo/NCIT_C8130) (Stage III Grade 2 Follicular Lymphoma), [NCIT:C8491](http://purl.obolibrary.org/obo/NCIT_C8491) (Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C68688](http://purl.obolibrary.org/obo/NCIT_C68688) (Stage II Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C68683](http://purl.obolibrary.org/obo/NCIT_C68683) (Stage IV Marginal Zone Lymphoma), [NCIT:C68684](http://purl.obolibrary.org/obo/NCIT_C68684) (Recurrent Marginal Zone Lymphoma), [NCIT:C68682](http://purl.obolibrary.org/obo/NCIT_C68682) (Stage III Marginal Zone Lymphoma), [NCIT:C37203](http://purl.obolibrary.org/obo/NCIT_C37203) (Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation), [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C3246](http://purl.obolibrary.org/obo/NCIT_C3246) (Mycosis Fungoides), [NCIT:C8656](http://purl.obolibrary.org/obo/NCIT_C8656) (Stage IV Lymphoplasmacytic Lymphoma), [NCIT:C7800](http://purl.obolibrary.org/obo/NCIT_C7800) (Stage III Mycosis Fungoides), [NCIT:C8654](http://purl.obolibrary.org/obo/NCIT_C8654) (Stage II Lymphoplasmacytic Lymphoma), [NCIT:C5264](http://purl.obolibrary.org/obo/NCIT_C5264) (Bronchial Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C115212](http://purl.obolibrary.org/obo/NCIT_C115212) (Familial Waldenstrom Macroglobulinemia), [NCIT:C8655](http://purl.obolibrary.org/obo/NCIT_C8655) (Stage III Lymphoplasmacytic Lymphoma), [NCIT:C5266](http://purl.obolibrary.org/obo/NCIT_C5266) (Gastric Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C8652](http://purl.obolibrary.org/obo/NCIT_C8652) (Refractory Lymphoplasmacytic Lymphoma), [NCIT:C8653](http://purl.obolibrary.org/obo/NCIT_C8653) (Stage I Lymphoplasmacytic Lymphoma), [NCIT:C9464](http://purl.obolibrary.org/obo/NCIT_C9464) (Grade 1 Diffuse Follicular Lymphoma), [NCIT:C80307](http://purl.obolibrary.org/obo/NCIT_C80307) (Waldenstrom Macroglobulinemia), [NCIT:C123394](http://purl.obolibrary.org/obo/NCIT_C123394) (Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C6918](http://purl.obolibrary.org/obo/NCIT_C6918) (Subcutaneous Panniculitis-Like T-Cell Lymphoma), [NCIT:C5635](http://purl.obolibrary.org/obo/NCIT_C5635) (Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C3898](http://purl.obolibrary.org/obo/NCIT_C3898) (Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C3212](http://purl.obolibrary.org/obo/NCIT_C3212) (Lymphoplasmacytic Lymphoma), [NCIT:C4663](http://purl.obolibrary.org/obo/NCIT_C4663) (Splenic Marginal Zone Lymphoma), [NCIT:C8867](http://purl.obolibrary.org/obo/NCIT_C8867) (Stage IV Nodal Marginal Zone Lymphoma), [NCIT:C80299](http://purl.obolibrary.org/obo/NCIT_C80299) (Pediatric Nodal Marginal Zone Lymphoma), [NCIT:C8865](http://purl.obolibrary.org/obo/NCIT_C8865) (Stage II Nodal Marginal Zone Lymphoma), [NCIT:C7217](http://purl.obolibrary.org/obo/NCIT_C7217) (Primary Cutaneous Follicle Center Lymphoma), [NCIT:C8866](http://purl.obolibrary.org/obo/NCIT_C8866) (Stage III Nodal Marginal Zone Lymphoma), [NCIT:C8863](http://purl.obolibrary.org/obo/NCIT_C8863) (Nodal Marginal Zone Lymphoma), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C4341](http://purl.obolibrary.org/obo/NCIT_C4341) (Marginal Zone Lymphoma), [NCIT:C8864](http://purl.obolibrary.org/obo/NCIT_C8864) (Stage I Nodal Marginal Zone Lymphoma), [NCIT:C8464](http://purl.obolibrary.org/obo/NCIT_C8464) (Stage I Indolent Adult Non-Hodgkin Lymphoma), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), [NCIT:C8072](http://purl.obolibrary.org/obo/NCIT_C8072) (Stage I Grade 2 Follicular Lymphoma), [NCIT:C39644](http://purl.obolibrary.org/obo/NCIT_C39644) (Mycosis Fungoides Variant), [NCIT:C8071](http://purl.obolibrary.org/obo/NCIT_C8071) (Stage I Grade 1 Follicular Lymphoma), [NCIT:C35688](http://purl.obolibrary.org/obo/NCIT_C35688) (Breast Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C127840](http://purl.obolibrary.org/obo/NCIT_C127840) (Recurrent Waldenstrom Macroglobulinemia), [NCIT:C96506](http://purl.obolibrary.org/obo/NCIT_C96506) (Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C35689](http://purl.obolibrary.org/obo/NCIT_C35689) (Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.66%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39711](http://purl.obolibrary.org/obo/NCIT_C39711) (C-KIT Tyrosine Kinase Protein Overexpression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39709](http://purl.obolibrary.org/obo/NCIT_C39709) (Confluent Sheets of Anaplastic T-Lymphocytes Present))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39708](http://purl.obolibrary.org/obo/NCIT_C39708) (Cerebriform-Like Lymphocyte))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3970](http://purl.obolibrary.org/obo/NCIT_C3970) (Kidney Cyst))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39695](http://purl.obolibrary.org/obo/NCIT_C39695) (Extranodal Disease))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39692](http://purl.obolibrary.org/obo/NCIT_C39692) (Complete Spontaneous Regression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39691](http://purl.obolibrary.org/obo/NCIT_C39691) (Partial Spontaneous Regression))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39690](http://purl.obolibrary.org/obo/NCIT_C39690) (Papular Lesion))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39689](http://purl.obolibrary.org/obo/NCIT_C39689) (Multicentric Cutaneous Involvement))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39688](http://purl.obolibrary.org/obo/NCIT_C39688) (Localized Skin Lesion))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39687](http://purl.obolibrary.org/obo/NCIT_C39687) (Activated Mature Cytotoxic T-Lymphocyte))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39686](http://purl.obolibrary.org/obo/NCIT_C39686) (Activated Skin-Homing T-Lymphocyte))) 39.90%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39682](http://purl.obolibrary.org/obo/NCIT_C39682) (Flower-Like T-Lymphocyte))) 39.90%


